A Systematic Search and Review of Registered Pharmacological Therapies Investigated to Improve Outcomes after a Stroke [0.03%]
系统性检索和综述注册的药理学治疗方案以改善卒中后预后的研究
Tsong-Hai Lee,Shinichiro Uchiyama,Yohanna Kusuma et al.
Tsong-Hai Lee et al.
Introduction: Stroke burden is largely due to long-term impairments requiring prolonged care and loss of productivity. We aim to identify and assess studies of different registered pharmacological therapies as treatments ...
Validation of Prognostic Scales for Functional Outcome in Ischemic Stroke Patients Treated with Intravenous Thrombolysis in a Rural Setting [0.03%]
在农村地区接受静脉溶栓治疗的缺血性卒中患者的功能预后量表的有效性验证
Andrea Loggini,Faddi G Saleh Velez,Jonatan Hornik et al.
Andrea Loggini et al.
Introduction: Early prediction of functional outcome after rtPA helps clinicians in prognostic conversations with stroke patients and their families. Three prognostic tools have been developed in this regard: DRAGON, MRI-...
Udaya K Ranawaka
Udaya K Ranawaka
Background: Many unusual and fascinating causes of stroke are seen in Asia. Although rarely encountered in the Western world, such cases are seen not so infrequently by neurologists, physicians, and other healthcare worke...
Safety and Efficacy Comparison of Tenecteplase and Alteplase for Clinically Suspected Large Vessel Occlusion Strokes without Thrombectomy [0.03%]
替奈普酶与 alteplase 治疗未行取栓的疑似大血管闭塞卒中的安全性及有效性比较
Wai Ting Lo,Wing Chi Fong,Chris Siu Kwan Chau et al.
Wai Ting Lo et al.
Introduction: Tenecteplase is a thrombolytic with higher fibrin affinity and is potentially better in clot lysis. A higher spontaneous recanalisation rate for large vessel occlusion (LVO) strokes had been shown in compari...
Comparative Study
Cerebrovascular diseases extra. 2024;14(1):134-140. DOI:10.1159/000540750 2024
Narayanaswamy Venketasubramanian,Kay Sin Tan,Jose C Navarro et al.
Narayanaswamy Venketasubramanian et al.
Exploring the Impact of Age and Pre-Stroke Modified Rankin Scale in Elderly Thrombectomy: A 15-Year Single-Center Experience [0.03%]
基于单中心十五年经验的机械取栓老年人群中年龄和术前mRS评分的影响研究
Brian Anthony B Enriquez,Heidi Kristine Halling,Christian Georg Lund et al.
Brian Anthony B Enriquez et al.
Introduction: The selection of endovascular thrombectomy (EVT) for acute ischemic stroke in the elderly remains challenging due to the underrepresentation of these patients in landmark randomized trials. The aim of this s...
Prevalence of RNF213 rs112735431 Genetic Polymorphism in Non-Cardioembolic Ischemic Cerebrovascular Disease: A Cross-Sectional Study in Thai Patients [0.03%]
泰国患者非心源性缺血性脑血管病中RNF213基因rs112735431多态性的患病率：一项横断面研究
Suporn Travanichakul,Aurauma Chutinet,Naruchorn Kijpaisalratana et al.
Suporn Travanichakul et al.
Introduction: Moyamoya disease (MMD) and non-MMD intracranial cerebral artery stenosis (ICAS) have been linked to the RNF213 rs112735431 gene in Korean and Japanese populations. This cross-sectional study investigates the...
Clinical Features and Treatment Outcomes in Patients in Their Twenties with Ischemic Moyamoya Disease [0.03%]
二十几岁动脉闭塞性 moyamoya 病患者的临床特征及治疗预后分析
Yutaro Ono,Yosuke Akamatsu,Shizuka Araya et al.
Yutaro Ono et al.
Introduction: Revascularization surgery is recommended for all pediatric patients with moyamoya disease (MMD) with ischemic symptoms because the brains of such patients are still developing. By contrast, no clear guidelin...
Comparative Study
Cerebrovascular diseases extra. 2024;14(1):105-115. DOI:10.1159/000540769 2024
Shinichiro Uchiyama,Miki Fujimura
Shinichiro Uchiyama
Background: Recent advances are in the genetics, diagnosis, pathophysiology, and management of moyamoya disease (MMD), and moyamoya syndrome (MMS), a term used to describe moyamoya-like vasculopathy associated with variou...